July 2019

01 Jul Cenetron Sells To Versiti

BroadOak Partners advised Cenetron Diagnostics (“Cenetron”) on the sale of the company to Versiti. Cenetron provides central laboratory services to support global clinical trials for biopharmaceutical, diagnostic, and contract research organizations. The full press release is below. Versiti Acquires Texas-based Cenetron Central Laboratories and Salus IRB to...